The A3S technology has been developed in order to eliminate any risks of bacterial and viral diseases spread through a pending patented (CA 2909198) biocidal effect treatment. We named this technology UmanProtek.
This technology is characterized by anodization of aluminium, which allows preparation of the surface for reception of the biocide treatment. The effectiveness of the biocidal agent’s active ingredients is thus combined with the mechanical resistance of anodized aluminum.
This ingenious combination makes UmanProtek technology an efficient, resistant, and versatile method for destroying infectious agents (A3S patent pending technology) (CA 2909198).